Retraction of the article: Ryazhenov V.V., Gorokhova S.G., Bunyatyan N.D. Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research by article Editorial

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Analysis of a sociological survey on information and educational needs of specialists in the field of medicines circulation as regards the issue of medicines interchangeability by N. G. Goloenko, R. I. Yagudina, B. K. Romanov, R. N. Alyautdin, D. G. Karapetyan, E. G. Zelenova, E. E. Arinina, A. Yu. Kulikov, M. V. Protsenko, G. T. Abdrashitova

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Complex Assessment of the Functional State of the Urinary System in Preclinical Studies. Part 1. Instrumental and Laboratory Assessment Methods (Review) by M. V. Miroshnikov, K. T. Sultanova, M. N. Makarova, N. M. Faustova, S. O. Khan, E. A. Loseva

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Determination of impurities in fixed vegetable oils by A. M. Kalinin, N. P. Antonova, S. S. Prokhvatilova, E. P. Shefer

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Features of toxic nephropathy development during antibiotic therapy by R. E. Kazakov, G. I. Gorodetskaya, R. V. Archvadze, A. V. Zavtonev, A. V. Danilov, D. L. Fetlam, D. A. Ishalev, N. G. Berdnikova, E. Yu. Demchenkova

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Current Approaches to Valerian Tincture Standardisation in Terms of Assay by N. P. Antonova, E. P. Shefer, A. M. Kalinin, N. E. Semenova, S. S. Prokhvatilova, I. M. Morgunov

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Effects of a New Kappa Agonist (Fluorophenyl Derivative of Imidazo[1,2-<i>а</i>]benzimidazole) on the Rat Genome by O. V. Verle, A. G. Sirekanyan, N. V. Eliseeva, Yu. V. Lifanova, A. A. Spasov, O. V. Ostrovsky

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

“We should strive to attain Russia’s former standing in nuclear medicine” by S. N. Kalmykov

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Preparation of Module 1 of the Registration Dossier According to the EAEU Procedure by E. M. Rychikhina

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Block Copolymers of Ethylene Oxide and Propylene Oxide: Prospects for Medical and Pharmaceutical Application in Russia by E. O. Bakhrushina, V. S. Pyzhov, P. S. Sakharova, N. B. Demina, D. A. Chizhova, T. V. Tabanskaya, M. F. Lutfullin

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Interpretation of toxicological research data in establishing the no observed adverse effect level (NOAEL) for medicinal products by K. L. Kryshen, Ya. A. Gushchin, N. M. Faustova, S. V. Gushchina, Zh. Yu. Ustenko, A. E. Katelnikova, K. T. Sultanova, A. A. Matichin, V. A. Vavilova, Ya. G. Murazov, M. V. Miroshnikov, M. A. Kovaleva, D. V. Shubin, V. G. Makarov, M. N. Makarova

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Analysis of the cost of pharmacotherapy of ischemic stroke in hospital in 2009-2011 by N. V. Mikheeva, O. V. Reshetko, S. I. Kurnosov

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Methods for Detecting Subvisible Particles in Medicines (Review) by S. I. Kuleshova, M. L. Goryunova, O. N. Vysochanskaya

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Standardisation of the method of residual organic solvent determination (review) by O. G. Kornilova, E. A. Smiryagin, V. L. Bagirova, M. A. Sumtsov

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Current Requirements for Information Content and Graphic Design of a Medicinal Product Package by L. I. Mit'kina, Anastasiya K. Ericheva

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Roles of Individual Institutions in Achieving Pharmaceutical Sovereignty as Exemplified by the Medical Technology Transfer Centre of the Scientific Centre for Expert Evaluation of... by A. S. Koshevenko, T. V. Degrave, P. V. Burenkov, K. Yu. Belanov, V. V. Kosenko

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Calendula Flowers (<i>Calendulae officinalis flos</i>): Methods to Obtain Fractions of Biologically Active Substances by R. I. Lukashou, N. S. Gurina

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Harmonization and updating as basic principles of the development of the Republic of Kazakhstan state pharmacopoeia by S. R. Musinov, A. U. Tulegenova

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

EXPERT APPROACHES TO EQUIVALENCE EVALUATION OF DRUGS — ANALOGUES OF ENDOGENOUS COMPOUNDS AS CONSISTENT WITH THE RUSSIAN LEGISLATION AND INTERNATIONAL LAW by D. P. Romodanovsky, D. V. Goryachev, A. P. Solovieva, I. V. Kokin, N. N. Eremenko

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text

Aetiopathogenetic Architecture for Pharmaceutical Development (Using Gout as a Case Study) by E. V. Avdeeva, N. R. Varina, T. K. Ryazanova, V. A. Kurkin, N. V. Isakova, L. T. Volova, D. A. Poltoretskii

“…Регуляторные исследования и экспертиза лекарственных средств…”
Get full text